Skip to main content
Top
Published in: Calcified Tissue International 2/2017

01-08-2017 | Original Research

Familial Early-Onset Paget’s Disease of Bone Associated with a Novel hnRNPA2B1 Mutation

Authors: Xuan Qi, Qianqian Pang, Jiawei Wang, Zhen Zhao, Ou Wang, Lijun Xu, Jiangfeng Mao, Yan Jiang, Mei Li, Xiaoping Xing, Wei Yu, Asan, Weibo Xia

Published in: Calcified Tissue International | Issue 2/2017

Login to get access

Abstract

Paget disease of bone (PDB) is a common metabolic bone disease characterized by increased bone resorption and disorganized bone formation which affect single or multiple sites of bones. Although the exact cause of PDB is still controversial, genetic factors are considered to play an important role in PDB. Several genes involved in the differentiation or function of osteoclast were shown to be associated with PDB or related syndrome such as SQSTM1, TNFRSF11A, TNFRSF11B, and ZNF687. Multisystem proteinopathy (MSP), a newly proposed syndrome including inclusion body myopathy (IBM), PDB, frontotemporal dementia (FTD), and amyotrophic lateral sclerosis (ALS), is mainly caused by mutation in VCP gene. In 2013, a new casual gene for MSP was identified as hnRNPA2B1 gene. This may partly account for the inherited PDB traits which is however negative for mutation in already known causative PDB genes. We investigated a Chinese family with multiple affected individuals with PDB, but none of the members showed symptoms of IBM, FTD, or ALS. Three patients were evaluated clinically, biochemically, and radiographically. To screen for the responsible mutation, whole-exome sequencing was conducted in the proband, another patient, as well as a normal individual from the family. This revealed a novel heterozygous missense mutation of hnRNPA2B1 gene (c.929C>T, p. P310L) in the two patients which was then verified in all affected individuals. We describe here a novel missense mutation in hnRNPA2B1 gene in a large pedigree affected with PDB with members who do not present other manifestations of multisystem proteinopathy, such as IBM, FTD, and ALS.
Appendix
Available only for authorised users
Literature
2.
go back to reference Falchetti A, Masi L, Brandi ML (2010) Paget’s disease of bone: there’s more than the affected skeletal–a clinical review and suggestions for the clinical practice. Curr Opin Rheumatol 22:410–423CrossRefPubMed Falchetti A, Masi L, Brandi ML (2010) Paget’s disease of bone: there’s more than the affected skeletal–a clinical review and suggestions for the clinical practice. Curr Opin Rheumatol 22:410–423CrossRefPubMed
3.
go back to reference van Staa TP, Selby P, Leufkens HG, Lyles K, Sprafka JM, Cooper C (2002) Incidence and natural history of Paget’s disease of bone in England and Wales. J Bone Miner Res 17:465–471CrossRefPubMed van Staa TP, Selby P, Leufkens HG, Lyles K, Sprafka JM, Cooper C (2002) Incidence and natural history of Paget’s disease of bone in England and Wales. J Bone Miner Res 17:465–471CrossRefPubMed
4.
go back to reference Poor G, Donath J, Fornet B, Cooper C (2006) Epidemiology of Paget’s disease in Europe: the prevalence is decreasing. J Bone Miner Res 21:1545–1549CrossRefPubMed Poor G, Donath J, Fornet B, Cooper C (2006) Epidemiology of Paget’s disease in Europe: the prevalence is decreasing. J Bone Miner Res 21:1545–1549CrossRefPubMed
5.
go back to reference Griz L, Caldas G, Bandeira C, Assuncao V, Bandeira F (2006) Paget’s disease of bone. Arq Bras Endocrinol Metabol 50:814–822CrossRefPubMed Griz L, Caldas G, Bandeira C, Assuncao V, Bandeira F (2006) Paget’s disease of bone. Arq Bras Endocrinol Metabol 50:814–822CrossRefPubMed
6.
go back to reference Tiegs RD, Lohse CM, Wollan PC, Melton LJ (2000) Long-term trends in the incidence of Paget’s disease of bone. Bone 27:423–427CrossRefPubMed Tiegs RD, Lohse CM, Wollan PC, Melton LJ (2000) Long-term trends in the incidence of Paget’s disease of bone. Bone 27:423–427CrossRefPubMed
9.
go back to reference Ralston SH, Albagha OM (2014) Genetics of Paget’s disease of bone. Curr Osteoporos Rep 12:263–271CrossRefPubMed Ralston SH, Albagha OM (2014) Genetics of Paget’s disease of bone. Curr Osteoporos Rep 12:263–271CrossRefPubMed
10.
go back to reference Divisato G, Formicola D, Esposito T, Merlotti D, Pazzaglia L, Del FA, Siris E, Orcel P, Brown JP, Nuti R, Strazzullo P, Benassi MS, Cancela ML, Michou L, Rendina D, Gennari L, Gianfrancesco F (2016) ZNF687 mutations in severe Paget disease of bone associated with giant cell tumor. Am J Hum Genet 98:275–286CrossRefPubMedPubMedCentral Divisato G, Formicola D, Esposito T, Merlotti D, Pazzaglia L, Del FA, Siris E, Orcel P, Brown JP, Nuti R, Strazzullo P, Benassi MS, Cancela ML, Michou L, Rendina D, Gennari L, Gianfrancesco F (2016) ZNF687 mutations in severe Paget disease of bone associated with giant cell tumor. Am J Hum Genet 98:275–286CrossRefPubMedPubMedCentral
11.
go back to reference Watts GD, Wymer J, Kovach MJ, Mehta SG, Mumm S, Darvish D, Pestronk A, Whyte MP, Kimonis VE (2004) Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein. Nat Genet 36:377–381CrossRefPubMed Watts GD, Wymer J, Kovach MJ, Mehta SG, Mumm S, Darvish D, Pestronk A, Whyte MP, Kimonis VE (2004) Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein. Nat Genet 36:377–381CrossRefPubMed
12.
go back to reference Kim HJ, Kim NC, Wang YD, Scarborough EA, Moore J, Diaz Z, MacLea KS, Freibaum B, Li S, Molliex A, Kanagaraj AP, Carter R, Boylan KB, Wojtas AM, Rademakers R, Pinkus JL, Greenberg SA, Trojanowski JQ, Traynor BJ, Smith BN, Topp S, Gkazi AS, Miller J, Shaw CE, Kottlors M, Kirschner J, Pestronk A, Li YR, Ford AF, Gitler AD, Benatar M, King OD, Kimonis VE, Ross ED, Weihl CC, Shorter J, Taylor JP (2013) Mutations in prion-like domains in hnRNPA2B1 and hnRNPA1 cause multisystem proteinopathy and ALS. Nature 495:467–473CrossRefPubMedPubMedCentral Kim HJ, Kim NC, Wang YD, Scarborough EA, Moore J, Diaz Z, MacLea KS, Freibaum B, Li S, Molliex A, Kanagaraj AP, Carter R, Boylan KB, Wojtas AM, Rademakers R, Pinkus JL, Greenberg SA, Trojanowski JQ, Traynor BJ, Smith BN, Topp S, Gkazi AS, Miller J, Shaw CE, Kottlors M, Kirschner J, Pestronk A, Li YR, Ford AF, Gitler AD, Benatar M, King OD, Kimonis VE, Ross ED, Weihl CC, Shorter J, Taylor JP (2013) Mutations in prion-like domains in hnRNPA2B1 and hnRNPA1 cause multisystem proteinopathy and ALS. Nature 495:467–473CrossRefPubMedPubMedCentral
13.
14.
go back to reference Liu G, Wei X, Chen R, Zhou H, Li X, Sun Y, Xie S, Zhu Q, Qu N, Yang G, Chu Y, Wu H, Lan Z, Wang J, Yang Y, Yi X (2014) A novel mutation of the SLC25A13 gene in a Chinese patient with citrin deficiency detected by target next-generation sequencing. Gene 533:547–553CrossRefPubMed Liu G, Wei X, Chen R, Zhou H, Li X, Sun Y, Xie S, Zhu Q, Qu N, Yang G, Chu Y, Wu H, Lan Z, Wang J, Yang Y, Yi X (2014) A novel mutation of the SLC25A13 gene in a Chinese patient with citrin deficiency detected by target next-generation sequencing. Gene 533:547–553CrossRefPubMed
15.
go back to reference Asan, Xu Y, Jiang H, Tyler-Smith C, Xue Y, Jiang T, Wang J, Wu M, Liu X, Tian G, Wang J, Wang J, Yang H, Zhang X (2011) Comprehensive comparison of three commercial human whole-exome capture platforms. Genome Biol 12:R95CrossRefPubMedPubMedCentral Asan, Xu Y, Jiang H, Tyler-Smith C, Xue Y, Jiang T, Wang J, Wu M, Liu X, Tian G, Wang J, Wang J, Yang H, Zhang X (2011) Comprehensive comparison of three commercial human whole-exome capture platforms. Genome Biol 12:R95CrossRefPubMedPubMedCentral
16.
go back to reference Wei X, Ju X, Yi X, Zhu Q, Qu N, Liu T, Chen Y, Jiang H, Yang G, Zhen R, Lan Z, Qi M, Wang J, Yang Y, Chu Y, Li X, Guang Y, Huang J (2011) Identification of sequence variants in genetic disease-causing genes using targeted next-generation sequencing. PLoS ONE 6:e29500CrossRefPubMedPubMedCentral Wei X, Ju X, Yi X, Zhu Q, Qu N, Liu T, Chen Y, Jiang H, Yang G, Zhen R, Lan Z, Qi M, Wang J, Yang Y, Chu Y, Li X, Guang Y, Huang J (2011) Identification of sequence variants in genetic disease-causing genes using targeted next-generation sequencing. PLoS ONE 6:e29500CrossRefPubMedPubMedCentral
18.
19.
go back to reference Alberti S, Halfmann R, King O, Kapila A, Lindquist S (2009) A systematic survey identifies prions and illuminates sequence features of prionogenic proteins. Cell 137:146–158CrossRefPubMedPubMedCentral Alberti S, Halfmann R, King O, Kapila A, Lindquist S (2009) A systematic survey identifies prions and illuminates sequence features of prionogenic proteins. Cell 137:146–158CrossRefPubMedPubMedCentral
20.
go back to reference Buratti E, Brindisi A, Giombi M, Tisminetzky S, Ayala YM, Baralle FE (2005) TDP-43 binds heterogeneous nuclear ribonucleoprotein A/B through its C-terminal tail: an important region for the inhibition of cystic fibrosis transmembrane conductance regulator exon 9 splicing. J Biol Chem 280:37572–37584CrossRefPubMed Buratti E, Brindisi A, Giombi M, Tisminetzky S, Ayala YM, Baralle FE (2005) TDP-43 binds heterogeneous nuclear ribonucleoprotein A/B through its C-terminal tail: an important region for the inhibition of cystic fibrosis transmembrane conductance regulator exon 9 splicing. J Biol Chem 280:37572–37584CrossRefPubMed
21.
go back to reference Xiang S, Kato M, Wu LC, Lin Y, Ding M, Zhang Y, Yu Y, McKnight SL (2015) The LC Domain of hnRNPA2 adopts similar conformations in hydrogel polymers, liquid-like droplets, and nuclei. Cell 163:829–839CrossRefPubMedPubMedCentral Xiang S, Kato M, Wu LC, Lin Y, Ding M, Zhang Y, Yu Y, McKnight SL (2015) The LC Domain of hnRNPA2 adopts similar conformations in hydrogel polymers, liquid-like droplets, and nuclei. Cell 163:829–839CrossRefPubMedPubMedCentral
22.
go back to reference Ralston SH, Langston AL, Reid IR (2008) Pathogenesis and management of Paget’s disease of bone. The Lancet 372:155–163CrossRef Ralston SH, Langston AL, Reid IR (2008) Pathogenesis and management of Paget’s disease of bone. The Lancet 372:155–163CrossRef
23.
go back to reference Shankar S, Hosking DJ (2006) Biochemical assessment of Paget’s disease of bone. J Bone Miner Res 21(Suppl 2):P22–P27CrossRefPubMed Shankar S, Hosking DJ (2006) Biochemical assessment of Paget’s disease of bone. J Bone Miner Res 21(Suppl 2):P22–P27CrossRefPubMed
24.
go back to reference Garnero P, Fledelius C, Gineyts E, Serre CM, Vignot E, Delmas PD (1997) Decreased beta-isomerization of the C-terminal telopeptide of type I collagen alpha 1 chain in Paget’s disease of bone. J Bone Miner Res 12:1407–1415CrossRefPubMed Garnero P, Fledelius C, Gineyts E, Serre CM, Vignot E, Delmas PD (1997) Decreased beta-isomerization of the C-terminal telopeptide of type I collagen alpha 1 chain in Paget’s disease of bone. J Bone Miner Res 12:1407–1415CrossRefPubMed
25.
go back to reference Cundy T, Rutland MD, Naot D, Bolland M (2015) Evolution of Paget’s disease of bone in adults inheriting SQSTM1 mutations. Clin Endocrinol (Oxf) 83:315–319CrossRef Cundy T, Rutland MD, Naot D, Bolland M (2015) Evolution of Paget’s disease of bone in adults inheriting SQSTM1 mutations. Clin Endocrinol (Oxf) 83:315–319CrossRef
26.
go back to reference Morissette J, Laurin N, Brown JP (2006) Sequestosome 1: mutation frequencies, haplotypes, and phenotypes in familial Paget’s disease of bone. J Bone Miner Res 21(Suppl 2):P38–P44CrossRefPubMed Morissette J, Laurin N, Brown JP (2006) Sequestosome 1: mutation frequencies, haplotypes, and phenotypes in familial Paget’s disease of bone. J Bone Miner Res 21(Suppl 2):P38–P44CrossRefPubMed
27.
go back to reference Bolland MJ, Tong PC, Naot D, Callon KE, Wattie DJ, Gamble GD, Cundy T (2007) Delayed development of Paget’s disease in offspring inheriting SQSTM1 mutations. J Bone Miner Res 22:411–415CrossRefPubMed Bolland MJ, Tong PC, Naot D, Callon KE, Wattie DJ, Gamble GD, Cundy T (2007) Delayed development of Paget’s disease in offspring inheriting SQSTM1 mutations. J Bone Miner Res 22:411–415CrossRefPubMed
28.
go back to reference Kimonis VE, Mehta SG, Fulchiero EC, Thomasova D, Pasquali M, Boycott K, Neilan EG, Kartashov A, Forman MS, Tucker S, Kimonis K, Mumm S, Whyte MP, Smith CD, Watts GD (2008) Clinical studies in familial VCP myopathy associated with Paget disease of bone and frontotemporal dementia. Am J Med Genet A 146A:745–757CrossRefPubMedPubMedCentral Kimonis VE, Mehta SG, Fulchiero EC, Thomasova D, Pasquali M, Boycott K, Neilan EG, Kartashov A, Forman MS, Tucker S, Kimonis K, Mumm S, Whyte MP, Smith CD, Watts GD (2008) Clinical studies in familial VCP myopathy associated with Paget disease of bone and frontotemporal dementia. Am J Med Genet A 146A:745–757CrossRefPubMedPubMedCentral
29.
go back to reference Calini D, Corrado L, Del BR, Gagliardi S, Pensato V, Verde F, Corti S, Mazzini L, Milani P, Castellotti B, Bertolin C, Soraru G, Cereda C, Comi GP, D’Alfonso S, Gellera C, Ticozzi N, Landers JE, Ratti A, Silani V (2013) Analysis of hnRNPA1, A2/B1, and A3 genes in patients with amyotrophic lateral sclerosis. Neurobiol Aging 34:2611–2695CrossRef Calini D, Corrado L, Del BR, Gagliardi S, Pensato V, Verde F, Corti S, Mazzini L, Milani P, Castellotti B, Bertolin C, Soraru G, Cereda C, Comi GP, D’Alfonso S, Gellera C, Ticozzi N, Landers JE, Ratti A, Silani V (2013) Analysis of hnRNPA1, A2/B1, and A3 genes in patients with amyotrophic lateral sclerosis. Neurobiol Aging 34:2611–2695CrossRef
30.
go back to reference Le Ber I, Van Bortel I, Nicolas G, Bouya-Ahmed K, Camuzat A, Wallon D, De Septenville A, Latouche M, Lattante S, Kabashi E, Jornea L, Hannequin D, Brice A (2014) hnRNPA2B1 and hnRNPA1 mutations are rare in patients with “multisystem proteinopathy” and frontotemporal lobar degeneration phenotypes. Neurobiol Aging 35:934–935PubMed Le Ber I, Van Bortel I, Nicolas G, Bouya-Ahmed K, Camuzat A, Wallon D, De Septenville A, Latouche M, Lattante S, Kabashi E, Jornea L, Hannequin D, Brice A (2014) hnRNPA2B1 and hnRNPA1 mutations are rare in patients with “multisystem proteinopathy” and frontotemporal lobar degeneration phenotypes. Neurobiol Aging 35:934–935PubMed
31.
go back to reference Seelen M, Visser AE, Overste DJ, Kim HJ, Palud A, Wong TH, van Swieten JC, Scheltens P, Voermans NC, Baas F, de Jong JM, van der Kooi AJ, de Visser M, Veldink JH, Taylor JP, Van Es MA, van den Berg LH (2014) No mutations in hnRNPA1 and hnRNPA2B1 in Dutch patients with amyotrophic lateral sclerosis, frontotemporal dementia, and inclusion body myopathy. Neurobiol Aging 35:1956–1959CrossRefPubMed Seelen M, Visser AE, Overste DJ, Kim HJ, Palud A, Wong TH, van Swieten JC, Scheltens P, Voermans NC, Baas F, de Jong JM, van der Kooi AJ, de Visser M, Veldink JH, Taylor JP, Van Es MA, van den Berg LH (2014) No mutations in hnRNPA1 and hnRNPA2B1 in Dutch patients with amyotrophic lateral sclerosis, frontotemporal dementia, and inclusion body myopathy. Neurobiol Aging 35:1956–1959CrossRefPubMed
Metadata
Title
Familial Early-Onset Paget’s Disease of Bone Associated with a Novel hnRNPA2B1 Mutation
Authors
Xuan Qi
Qianqian Pang
Jiawei Wang
Zhen Zhao
Ou Wang
Lijun Xu
Jiangfeng Mao
Yan Jiang
Mei Li
Xiaoping Xing
Wei Yu
Asan
Weibo Xia
Publication date
01-08-2017
Publisher
Springer US
Published in
Calcified Tissue International / Issue 2/2017
Print ISSN: 0171-967X
Electronic ISSN: 1432-0827
DOI
https://doi.org/10.1007/s00223-017-0269-0

Other articles of this Issue 2/2017

Calcified Tissue International 2/2017 Go to the issue